首页 | 本学科首页   官方微博 | 高级检索  
检索        

曲美他嗪治疗缺血性心脏病心功能不全60例临床分析
引用本文:赵焕东.曲美他嗪治疗缺血性心脏病心功能不全60例临床分析[J].实用全科医学,2011(11):1727-1728.
作者姓名:赵焕东
作者单位:河南省永城市第五人民医院心内科;
摘    要:目的观察曲美他嗪治疗缺血性心脏病心功能不全的临床疗效及安全性。方法选择116例缺血性心脏病心功能不全患者随机分为治疗组60例和对照组成56例。对照组给予正规抗心力衰竭治疗;治疗组在对照组常规治疗基础上加服曲美他嗪20 mg,3次/d。两组疗程均为6个月。观察两组治疗前后临床疗效、左室舒张末内径(LVEDD)、左室射血分数(LVEF)、血清B型尿钠肽(BNP)、6分钟步行试验及药物不良反应等。结果治疗6个月后,治疗组的总有效率为93.3%,显著高于对照组的75.0%(P〈0.05);在LVEDD、LVEF、6分钟步行距离结果及BNP改善的程度等方面,治疗组均优于对照组(P〈0.05);治疗组发生药物不良反应少而轻微。结论缺血性心脏病心功能不全患者长期服用曲美他嗪可使心功能改善,安全有效。

关 键 词:曲美他嗪  缺血性心脏病  心功能不全

Therapeutic Effect of Trimetazidine in Treating Cardiac Dysfunction in 60 Patients with Ischemic Heart Disease
ZHAO Huan-dong.Therapeutic Effect of Trimetazidine in Treating Cardiac Dysfunction in 60 Patients with Ischemic Heart Disease[J].Applied Journal Of General Practice,2011(11):1727-1728.
Authors:ZHAO Huan-dong
Institution:ZHAO Huan-dong.Department of Cardiology,the Fifth People's Hospital of Yongcheng,Yongcheng 476600,He'nan,China
Abstract:Objective To investigate the clinical efficacy and safety of trimetazidine for the cardiac dysfunction in patients with ischemic heart disease.Methods One hundred and sixteen patients with ischemic heart disease and cardiac dysfunction were randomly divided into treatment group(60 cases) and control group(56 cases).The control group received the conventional anti-heart failure therapy;while the treatment group received trimetazidine treatment(20 mg,three times a day) based on the conventional therapy.After ...
Keywords:Trimetazidine  Ischemic heart disease  Cardiac dysfunction  
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号